After three of its former employees were arrested last year for allegedly stealing trade secrets and giving confidential information to JHL Biotech, Genentech has struck a far-reaching settlement in a related lawsuit with the Taiwanese company.

In a statement, the Roche (RHHBY) unit disclosed that JHL agreed to destroy the data, not share the information with others, or use it to develop any medicines. Moreover, JHL agreed to allow Genentech to conduct unannounced audits to ensure compliance and make an undisclosed payment. The deal does not affect a criminal case filed by the feds, which is scheduled to go to trial in April 2020.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy